- $90.06m
- $68.57m
- $0.13m
Brief: Predictive Oncology Announces Collaboration With Integra Therapeutics
Predictive Oncology Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Predictive Oncology, Cancer Research Horizons Partners For Cancer Drugs
Brief: Predictive Oncology Says It Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Brief: Predictive Oncology Issues Letter To Shareholders
Brief: Predictive Oncology Reports Third Quarter Financial Results
Brief: David S. Smith Appointed To The Board Of Directors Of Predictive Oncology
Brief: Predictive Oncology Announces New CEO Raymond F. Vennare
Brief: Predictive Oncology Announces CEO Retirement
Brief: Predictive Oncology Reports Second Quarter 2022 Financial Results
Brief: Predictive Oncology Announces $7.2 Million Registered Direct Offerings
Brief: Predictive Oncology- Got Letter From Staff Of Nasdaq That Co Is Not In Compliance With The Minimum Bid Price Requirement For Continued Listing
Brief: Predictive Oncology Reports First Quarter Financial Results
Predictive Oncology Inc expected to post a loss of 4 cents a share - Earnings Preview
Predictive Oncology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Predictive Oncology Says On March 31, Nasdaq Notified Co That It Determined That Co Has Regained Compliance With Nasdaq Listing Rule
Predictive Oncology Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Predictive Oncology Validates Discovery 21 Proof-Of-Concept Campaign
Predictive Oncology Inc expected to post a loss of 2cents a share - Earnings Preview